系统性硬化症中的肌少症或肌肉脂肪变性具有临床相关性吗?基于计算机断层扫描的骨骼肌评估
该研究纳入2000-2024年在Gazi大学风湿科随访且接受胸部CT的系统性硬化症患者95例,于L1椎体层面测量骨骼肌面积与放射衰减,评估肌少症与肌肉脂肪变性患病率及其与临床特征的关系。结果显示肌肉脂肪变性患病率41.1%,与女性、年龄、BMI及炎症指标相关,且与食管扩张相关;肌少症患病率27.3%,仅与BMI相关,与临床结局无关。
要点
- 系统性硬化症患者肌肉脂肪变性患病率41.1%,高于肌少症的27.3%。
- L1层面SMRA降低与食管最宽径增大相关(p=0.001)。
- 肌肉脂肪变性与女性、年龄、BMI及CRP/ESR等炎症指标相关。
核心结论
- 肌肉脂肪变性较肌少症更常见,且与包括肺病和食管扩张在内的临床特征密切相关,提示肌肉质量评估的重要性。
研究设计与样本
- 回顾性纳入2000-2024年Gazi大学风湿科随访、接受胸部CT的系统性硬化症患者95例,于L1椎体层面测量骨骼肌面积(SMA)和骨骼肌放射衰减(SMRA)以判定肌少症和肌肉脂肪变性。
关键影像表现/征象
- 在L1椎体层面测量SMA和SMRA,用于识别肌少症和肌肉脂肪变性。
- 通过CT评估肺部病变累及情况和食管最宽径(WED)。
- 较高的WED与较低的SMRA相关(p=0.001)。
诊断标准与关键数值
- 肌少症患病率为27.3%,肌肉脂肪变性患病率为41.1%。
- BMI预测肌肉量(R²=0.42),年龄、性别和BMI决定SMRA(R²=0.67,p<0.001)。
- 肌肉脂肪变性与女性(p=0.001)、年龄较大(p=0.001)、较高BMI(p=0.043)及炎症标志物(CRP、ESR)相关。
- 肌少症与BMI相关(p=0.001),但与临床结局无关。
临床应用与阅片要点
- 在系统性硬化症患者胸部CT阅片时,可于L1层面评估骨骼肌面积与放射衰减,以识别肌少症和肌肉脂肪变性。
- 肌肉脂肪变性较肌少症更常见,且与食管扩张和肺病等临床特征相关,阅片时可关注肌肉密度减低。
- 肌少症与临床结局无关,而肌肉脂肪变性与炎症指标及食管扩张相关,评估时应侧重肌肉质量而非仅肌肉量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis, vascular damage, and immune dysregulation, often leading to muscle abnormalities. This study aimed to evaluate the prevalence of myopenia and myosteatosis in SSc patients using computed tomography (CT) and their associations with clinical features, including lung disease and esophageal dilatation.
MATERIALS AND METHODS: SSc patients followed at Gazi University Rheumatology Clinic (2000-2024) who had thoracic CT imaging were included. Muscle mass and density were assessed at the L1 vertebral level. Skeletal muscle area (SMA) and skeletal muscle radiation attenuation (SMRA) were measured to identify myopenia and myosteatosis. Lung disease involvement and widest esophageal diameter (WED) were assessed via CT. Statistical analyses explored correlations between muscle metrics and clinical variables, with multiple linear regression identifying predictors.
RESULTS: Among 95 patients (54.7% diffuse SSc, 45.3% limited SSc; mean age 57.04 ± 13.65 years; female-to-male ratio 8.5:1), myopenia and myosteatosis prevalence were 27.3% and 41.1%, respectively. Myosteatosis was associated with female sex (p = 0.001), older age (p = 0.001), higher BMI (p = 0.043), and inflammation markers (CRP, ESR). Myopenia correlated with BMI (p = 0.001) but not clinical outcomes. Higher WED correlated with lower SMRA (p = 0.001). BMI predicted muscle mass (R² = 0.42), while age, gender, and BMI determined SMRA (R² = 0.67, p < 0.001).
CONCLUSIONS: Myosteatosis was more prevalent and strongly associated with clinical features, including lung disease and esophageal dilatation, than myopenia, underscoring the importance of muscle quality.
引用
- Kılıç ACK, Vasi İ, Kılıç HK, et al. Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography. Acad Radiol. 2025. PMID: 40037937. doi:10.1016/j.acra.2025.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。